Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 5/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | KCNE1 | P15382 | 3/20 | 0.33 |
| ▸ | KCNQ1 | P51787 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9359331 | 1.00 | KCNA5 (0.38) | KCNA5ABCB1IDO1PARP1CNR1 | |
| SCHEMBL5868080 | 1.00 | KCNA5 (0.38) | KCNA5ABCB1IDO1PARP1CNR1 | |
| SCHEMBL6275053 | 1.00 | KCNA5 (0.38) | KCNA5ABCB1IDO1PARP1CNR1 | |
| SCHEMBL2828711 | 0.81 | SELL (0.42) | ABCB1 | |
| SCHEMBL5868353 | 0.79 | IDO1 (0.40) | ABCB1IDO1 | |
| SCHEMBL5868357 | 0.79 | IDO1 (0.40) | ABCB1IDO1 | |
| SCHEMBL6274078 | 0.79 | IDO1 (0.40) | ABCB1IDO1 | |
| SCHEMBL8947007 | 0.78 | IDO1 (0.36) | ABCB1IDO1KCNE1KCNQ1 | |
| SCHEMBL8947011 | 0.78 | IDO1 (0.36) | ABCB1IDO1KCNE1KCNQ1 | |
| SCHEMBL482484 | 0.78 | KCNE1 (0.47) | KCNE1KCNQ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7041700-B2 | Substituted benzopyran derivatives against arrhythmia | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2006-05-09 | — | — | US | disclosed |
| US-20040152763-A1 | Substituted benzopyran derivatives against arrhythmia | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152763-A1 | Substituted benzopyran derivatives against arrhythmia | CBR1, KCNH1, SCN8A | KCNA5 37/4885ABCB1 214/4885IDO1 2253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.